Copyright
©The Author(s) 2021.
World J Clin Cases. Jul 26, 2021; 9(21): 5840-5849
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5840
Published online Jul 26, 2021. doi: 10.12998/wjcc.v9.i21.5840
Table 4 Comparison of medical research council scores between the two groups (mean ± SD)
| Group | n | MRC | t | P value | |
| Before intervention | After intervention | ||||
| Refined care | 61 | 3.44 ± 0.52 | 1.82 ± 0.50 | 17.387 | 0.000 |
| Control | 59 | 3.58 ± 0.60 | 2.10 ± 0.55 | 14.072 | 0.000 |
| t | -1.367 | -2.920 | |||
| P value | 0.174 | 0.004 | |||
- Citation: Na N, Guo SL, Zhang YY, Ye M, Zhang N, Wu GX, Ma LW. Value of refined care in patients with acute exacerbation of chronic obstructive pulmonary disease. World J Clin Cases 2021; 9(21): 5840-5849
- URL: https://www.wjgnet.com/2307-8960/full/v9/i21/5840.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i21.5840